𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is impact of fatigue an independent factor associated with physical activity in patients with idiopathic Parkinson's disease?

✍ Scribed by Roy Elbers; Erwin E.H. van Wegen; Lynn Rochester; Victoria Hetherington; Alice Nieuwboer; Anne-Marie Willems; Diana Jones; Gert Kwakkel


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
84 KB
Volume
24
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

To investigate the longitudinal association between fatigue and physical activity in Parkinson's disease (PD) and determine whether this association is distorted by potential confounders. Data from baseline, 3, 6, and 12 week assessments in a single blind randomized clinical trial with cross‐over design were used (N = 153). The Multidimensional Fatigue Inventory (MFI) was used to assess fatigue and an activity monitor to measure amount of physical activity (defined as % dynamic activity during each monitoring session). Time‐independent and time‐dependent factors were investigated for their possible univariate association with dynamic activity. Random coefficient analysis was applied. Candidate confounders were successively added to the longitudinal association model to determine if the association between dynamic activity and fatigue was distorted. A proportional change beyond 15% was considered to be significant. Fatigue was significantly associated with physical activity (β = −0.099, SE = 0.032, P = 0.002). This association was not significantly distorted by type of intervention, age, gender, social support, disease duration, disease severity, motor impairment, cognition, anxiety, or medication intake. Depression caused proportional change of 22.2% in the regression coefficient of MFI. After controlling for depression, a significant association between MFI and dynamic activity remained (β = −0.121, SE = 0.036, P = 0.000). The association found between fatigue and dynamic activity suggests that patients who experience higher levels of fatigue are less physically active. However, the total explained variance of dynamic activity by fatigue alone was small, suggesting that fatigue is only a minor factor in the complex of behavioral aspects that affect the amount of physical activity in patients with PD. © 2009 Movement Disorder Society


📜 SIMILAR VOLUMES


Apolipoprotein A-IV is an independent pr
✍ Uli C. Broedl; Veronika Schachinger; Arno Lingenhel; Michael Lehrke; Renee Stark 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Background: Apoa-iv, an apolipoprotein (apo) with antioxidant, antiatherogenic, and antiinflammatory properties, was recently demonstrated to inhibit dextran sulfate sodium (dss)-induced experimental colitis in mice. we therefore hypothesized that apoa-iv may be associated with disease activity

Nonmotor symptoms are independently asso
✍ Huijuan Li; Meifen Zhang; Ling Chen; June Zhang; Zhong Pei; Ailing Hu; Qing Wang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract We performed a cross‐sectional study of 82 Chinese patients with Parkinson's disease (PD) enrolled during an 18‐month period using a clinical interview to assess the prevalence of nonmotor symptoms (NMS), the association with disease severity and motor status, and the impact on patients

Trunk muscle strength, but not trunk rig
✍ Marco Y.C. Pang; Margaret K.Y. Mak 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract Previous literature suggested that muscle forces applied to the skeleton may be an important factor in increasing bone mineral density (BMD). This purpose of this study was to determine whether trunk rigidity and trunk muscle strength were associated with lumbar spine BMD in patients wi

Long-term benefits of rivastigmine in de
✍ Werner Poewe; Erik Wolters; Murat Emre; Marco Onofrj; Chuanchieh Hsu; Sibel Teki 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract In patients with dementia associated with Parkinson's disease (PD), the efficacy and safety of rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase, were previously demonstrated in a 24‐week double‐blind placebo‐controlled trial. Our objective was to determine wh

Idiopathic immune-mediated acquired von
✍ Alhumood, Salah A.; Devine, Dana V.; Lawson, Laurie; Nantel, Stephen H.; Carter, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

A case of idiopathic immune-mediated von Willebrand's disease (AvWD) associated angiodysplasia and recurrent lower gastrointestinal bleeding is reported. Coagulation parameters at presentation were activated partial thromboplastin time of 41 sec, bleeding time >15 min, factor VIII procoagulant activ